Home / Germany / Regulus Therapeutics INC
Regulus Therapeutics INC
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
12 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
August 1, 2019 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| September 24, 2019 | Squarepoint OPS LLC | 0.46% | still open |
| September 19, 2019 | Squarepoint OPS LLC | 0.58% | still open |
| September 16, 2019 | Squarepoint OPS LLC | 0.69% | still open |
| September 11, 2019 | Squarepoint OPS LLC | 0.78% | still open |
| September 9, 2019 | Squarepoint OPS LLC | 0.89% | still open |
| September 5, 2019 | Squarepoint OPS LLC | 0.97% | still open |
| August 30, 2019 | Squarepoint OPS LLC | 1.09% | still open |
| August 28, 2019 | Squarepoint OPS LLC | 1.19% | still open |
| August 23, 2019 | Squarepoint OPS LLC | 1.29% | still open |
| August 20, 2019 | Squarepoint OPS LLC | 1.39% | still open |
| August 5, 2019 | Squarepoint OPS LLC | 1.40% | still open |
| August 1, 2019 | Squarepoint OPS LLC | 1.36% | still open |
Other companies sold short in Germany
- TUI AG 9.00% of the capital sold short
- AUTO1 Group SE 7.29% of the capital sold short
- HelloFresh SE 7.00% of the capital sold short
- Gerresheimer AG 6.46% of the capital sold short
- Hugo Boss AG 6.18% of the capital sold short
- Cancom SE 5.46% of the capital sold short
- PVA TePla AG 5.30% of the capital sold short
- Zalando SE 5.23% of the capital sold short
- LANXESS Aktiengesellschaft 5.11% of the capital sold short
- TAG Immobilien AG 4.99% of the capital sold short
- Tamboran Resources Corp. 4.96% of the capital sold short
- Kontron AG 4.94% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Regulus Therapeutics INC, source Bundesanzeiger, data as at September 24, 2019, https://www.quivad.com/action/regulus-therapeutics-inc